A detailed history of Virtu Financial LLC transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Virtu Financial LLC holds 14,433 shares of GOSS stock, worth $12,989. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,433
Previous 32,897 56.13%
Holding current value
$12,989
Previous $30,000 43.33%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 20, 2024

SELL
$0.8 - $1.51 $14,771 - $27,880
-18,464 Reduced 56.13%
14,433 $17,000
Q4 2023

Feb 26, 2024

BUY
$0.48 - $1.08 $15,790 - $35,528
32,897 New
32,897 $30,000
Q3 2022

Nov 07, 2022

BUY
$7.21 - $14.88 $112,209 - $231,577
15,563 New
15,563 $186,000
Q1 2021

May 19, 2021

SELL
$8.63 - $10.94 $114,399 - $145,020
-13,256 Closed
0 $0
Q4 2020

Feb 24, 2021

BUY
$8.3 - $13.59 $110,024 - $180,149
13,256 New
13,256 $128,000
Q3 2020

Dec 11, 2020

SELL
$11.3 - $14.75 $154,098 - $201,145
-13,637 Closed
0 $0
Q2 2020

Aug 07, 2020

BUY
$9.52 - $15.98 $129,824 - $217,919
13,637 New
13,637 $177,000

Others Institutions Holding GOSS

About Gossamer Bio, Inc.


  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $84.6M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.